Scientists have found a way to restore vision

< /p> 0

A group of scientists led by a biologist from the University of California at Riverside reports that the drug- an estrogen receptor ligand called indazole chloride (IndCl) may improve vision in patients with multiple sclerosis (MS).

Research was performed on an animal model of MS. Scientists used IndCl to evaluate its effects on demyelinating axons of the visual pathway. Their damage is responsible for vision loss in people with MS. The treatment induced remyelination and alleviated some axonal damage, leading to partial functional improvement of vision.

“We treated mice with multiple sclerosis with IndCl at the peak of the disease,” says Seema Tiwari-Woodruff, professor of biomedical sciences. of Sciences at the University of California, Riverside School of Medicine and the lead author of the study.

Scientists emphasize that if the brain is severely damaged, some of the axons that could potentially restore visual function are excessively damaged.

“There is a point of no return. Our article emphasizes that in order to improve vision by 75-80%, treatment should begin as early as possible,” the authors note.